Discovery Biology undertakes both basic and applied research in drug discovery, primarily in the areas of cancer and neglected diseases. We develop innovative technological approaches for high throughput screening, Hit-to-Lead and lead optimization, with a focus on imaging.
Find out more about our research.
Basic research into cancer pathways and high throughput screening for novel treatments in prostate, breast and pancreatic cancer. Learn more.
High throughput screening for anti-malarial compounds and development of stage-specific anti-malarial assays. Learn more.
High throughput screening and assay development for identification of novel treatments for Trypanosomiasis. Learn more.
Custom algorithm development for analysis of cellular targets and high throughput screening automation. Learn more.
